Floatz logo

Polyethylene Glycol 3350

Colon Carcinoma

Braintree LaboratoriesUNKNOWNPhase 3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
65/ 100

Competitive context

154 Active assets in the Colon Carcinoma cohort.

Asset / SponsorPhaseRating
Floxuridine
City of Hope Medical Center
Phase 2BBB
Fluorouracilum
Akeso
Phase 4BB
Pertuzumab
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3BB
Xaliplatin
Sun Yat-sen University
Phase 3BB
Trastuzumab
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3BB

View all 50 →

Same molecule, other indications

Polyethylene Glycol 3350 is also rated in:

constipation disorderActive
BB
Indicative · Phase 4
65 / 100
View asset →
kidney cancerActive
B
Indicative · Phase 4
59 / 100
View asset →
prostate cancerActive
CCC
Indicative · Phase 4
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →